Cargando…

Impact of HPV vaccination with Gardasil® in Switzerland

BACKGROUND: Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomaviruses (HPV), has been offered to 11–14 year-old schoolgirls in Switzerland since 2008. To evaluate its success and its potential impact on cervical cancer screening, HPV genotypes were ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacot-Guillarmod, Martine, Pasquier, Jérôme, Greub, Gilbert, Bongiovanni, Massimo, Achtari, Chahin, Sahli, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741926/ https://www.ncbi.nlm.nih.gov/pubmed/29273004 http://dx.doi.org/10.1186/s12879-017-2867-x

Ejemplares similares

Update on Safety and Efficacy of HPV Vaccines: Focus on Gardasil
por: Soliman, Monica, et al.
Publicado: (2021)

Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol
por: Pache, Basile, et al.
Publicado: (2022)

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination
por: Roy, Vicky, et al.
Publicado: (2023)

School-based HPV Vaccination: Variation in Inter-school Vaccine Uptake not Influenced by the Introduction of a New Information Brochure
por: Froidevaux, Laurel, et al.
Publicado: (2023)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix(®) or Gardasil(®) Vaccine
por: Godi, Anna, et al.
Publicado: (2015)

HPV Type 6 and 18 Coinfection in a Case of Adult-Onset Laryngeal Papillomatosis: Immunization with Gardasil
por: Fancello, Virginia, et al.
Publicado: (2015)

Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection
por: Zurek Munk-Madsen, Maria, et al.
Publicado: (2017)

Cervical intraepithelial neoplasia grade 3 in a patient following Gardasil vaccination
por: McLucas, Bruce, et al.
Publicado: (2019)

A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model
por: Yin, Fei, et al.
Publicado: (2017)

Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard(®)
por: Halfon, Philippe, et al.
Publicado: (2010)

Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women
por: Luna, Joaquin, et al.
Publicado: (2013)

Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery
por: Gountas, Ilias, et al.
Publicado: (2023)

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil(®))
por: Govan, Vandana A
Publicado: (2008)

A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix(®) and Gardasil(®) Human Papillomavirus Vaccines in 12-15 Year Old Girls
por: Draper, Eve, et al.
Publicado: (2013)

Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial
por: Bourgeois, Florence, et al.
Publicado: (2020)

Safety and Efficacy of an Atraumatic Uterine Cervical Traction Device: A Pilot Study
por: Legardeur, Hélène, et al.
Publicado: (2021)

EPH114 Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery
por: Gountas, I, et al.
Publicado: (2022)

HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in Italy
por: Nicoli, Francesco, et al.
Publicado: (2020)

The Phantom Urine: An Unexpected Finding during a Routine Cesarean Section
por: Pagnozza, Maria, et al.
Publicado: (2014)

Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial Neoplasia: A Meta-analysis
por: Haghshenas, Mohammad Reza, et al.
Publicado: (2017)

Predictive Factors Involved in Postpartum Regressions of Cytological/Histological Cervical High-Grade Dysplasia Diagnosed during Pregnancy
por: Gomez, Yvan, et al.
Publicado: (2021)

Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature
por: Wetterwald, Laureline, et al.
Publicado: (2023)

High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N’Djamena, Chad
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2019)

Nested Species Distribution Models of Chlamydiales in Ixodes ricinus (Tick) Hosts in Switzerland
por: Rochat, Estelle, et al.
Publicado: (2020)

Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial”
por: Garland, Suzanne M., et al.
Publicado: (2020)

Prevalence and Consequences of Preoperative Weight Loss in Gynecologic Surgery
por: Pache, Basile, et al.
Publicado: (2019)

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Teixeira Farinha, Hugo, et al.
Publicado: (2017)

Women with Cervical High-Risk Human Papillomavirus: Be Aware of Your Anus! The ANGY Cross-Sectional Clinical Study
por: Jacot-Guillarmod, Martine, et al.
Publicado: (2022)

Impact of HPV vaccination on HPV-related oral infections
por: Gheit, Tarik, et al.
Publicado: (2023)

Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses
por: Jacot, Damien, et al.
Publicado: (2020)

Assessment of SARS-CoV-2 Genome Sequencing: Quality Criteria and Low-Frequency Variants
por: Jacot, Damien, et al.
Publicado: (2021)

Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study
por: Kiener, Laura M, et al.
Publicado: (2022)

Characteristics of complementary medicine therapists in Switzerland: A cross-sectional study
por: Dubois, Julie, et al.
Publicado: (2019)

Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland
por: Kind, André B., et al.
Publicado: (2020)

Osteopathy in the French-speaking part of Switzerland: Practitioners’ profile and scope of back pain management
por: Bill, Anne-Sylvie, et al.
Publicado: (2020)

Vaccination in Switzerland
Publicado: (1877)

HPV vaccine awareness, knowledge and information sources among youth in Switzerland: a mixed methods study
por: Schwendener, Corina L, et al.
Publicado: (2022)

Comparison of pelvic floor dysfunction 6 years after uncomplicated vaginal versus elective cesarean deliveries: a cross-sectional study
por: Baud, David, et al.
Publicado: (2020)

HIV testing in termination of pregnancy and colposcopy services: a scoping review
por: Filippidis, Paraskevas, et al.
Publicado: (2022)

Adolescent pregnancy: An important issue for paediatricians and primary care providers—A position paper from the European academy of paediatrics
por: Vieira Martins, Miguel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3058hrlbpo5vtgnk8qiq5ib5ft